Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans

Journal of the American College of Cardiology

Volumn 61, Issue 7, 2013, Pages 723-727

  Wittfeldt, Ann ^a   Emanuelsson, Håkan ^b   Brandrup Wognsen, Gunnar ^a,b   Van Giezen, J J J ^b   Jonasson, Jenny ^b   Nylander, Sven ^b   Gan, Li Ming ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

adenosine; coronary blood flow; dyspnea; ticagrelor

Indexed keywords

ADENOSINE; DRUG METABOLITE; PLACEBO; THEOPHYLLINE; TICAGRELOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; ATRIOVENTRICULAR BLOCK; BLOOD FLOW VELOCITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DYSPNEA; HUMAN; HUMAN EXPERIMENT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADENOSINE; ADOLESCENT; ADULT; BLOOD FLOW VELOCITY; CORONARY VESSELS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG SYNERGISM; HUMANS; MALE; PURINERGIC P2Y RECEPTOR ANTAGONISTS; UP-REGULATION; VASODILATION; YOUNG ADULT;

EID: 84873712137     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.11.032     Document Type: Article

References (12)

1. J.J. van Giezen, W. Tomlinson, P. Berntsson AZD6140 (ticagrelor) binds to the human P2Y12 receptor independently from ADP, but antagonizes ADP-induced receptor signaling and platelet aggregation J Thromb Haemost 7 2009 1556 1565
2. L. Wallentin, R.C. Becker, A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
3. J.J. van Giezen, J. Sidaway, P. Glaves, I. Kirk, J.A. Björkman Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model J Cardiovasc Pharmacol Ther 17 2011 164 172
4. N.K. Burki, W.J. Dale, L.Y. Lee Intravenous adenosine and dyspnea in humans J Appl Physiol 98 2005 180 185
5. B.B. Lerman, L. Belardinelli Cardiac electrophysiology of adenosine Basic and clinical concepts Circulation 83 1991 1499 1509
6. U. Hägg, B. Wandt, G. Bergström, R. Volkmann, L.M. Gan Physical exercise capacity is associated with coronary and peripheral vascular function in healthy young adults Am J Physiol Heart Circ Physiol 289 2005 H1627 H1634
7. H. Sillén, M. Cook, P. Davis Determination of ticagrelor and two metabolites in plasma samples by liquid chromatography and mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 878 2010 2299 2306
8. B.B. Fredholm Adenosine, an endogenous distress signal, modulates tissue damage and repair Cell Death Differ 14 2007 1315 1323
9. S. Nylander, E. Femia, M. Scavone Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism Arterioscler Thromb Vasc Biol 32 2012 A213
10. K.W. Mahaffey, J.A. Puma, N.A. Barbagelata Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of Adenosine (AMISTAD) trial J Am Coll Cardiol 34 1999 1711 1720
11. A.M. Ross, R.J. Gibbons, G.W. Stone, R.A. Kloner, R.W. Alexander AMISTAD-II Investigators A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) J Am Coll Cardiol 45 2005 1775 1780
12. B.M. Scirica, C.P. Cannon, H. Emanuelsson The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy J Am Coll Cardiol 57 2011 1908 1916